arrow
K

Kareem Jamani

Cumming School of Medicine
H指数:15
被引数:720

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival

真实世界中,关于重度预治疗且对糖皮质激素难治的慢性移植物抗宿主病患者接受belumosudil治疗的加拿大数据:治疗结局及无失败生存期的风险因素分析

2025-10-250
OA
Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment

内皮活化与应激指数(EASIX)作为预测鲁索利替尼治疗糖皮质激素难治性急性移植物抗宿主病的失败生物标志物

2025-09-140
OAAI
Real-World Efficacy of Belumosudil in Treating Fibrotic Symptom Burden in Chronic Gvhd: Modified Lee Symptom Score Assessment after Multiple Treatment Failures

Belumosudile在治疗慢性移植物抗宿主病纤维化症状负担中的真实世界疗效:多次治疗失败后的改良Lee症状评分评估

BLOOD
IF23.1
2024-11-050
PRE
Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis
2023-11-155
OAAI
Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease

清髓性和抗胸腺细胞球蛋白条件造血细胞移植后的不完全嵌合是复发和慢性移植物抗宿主病的危险因素

2022-12-013
PRE
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
2022-06-018
OAAI
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation

造血干细胞移植后淋巴组织增生性疾病发病和死亡的危险因素

2022-01-0119
OAAI
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States

在美国异基因造血细胞移植的年轻成年幸存者中重返工作

2021-08-0114
OAAI